4
INTRODUCTION
In recent years, the incidence of breast cancer has
increased, being the most common cancer in
women according to the World Health Organization
(WHO), representing 16% of all cancers in women
(1). It is estimated that 1.38 million new cases are
detected each year and this figure continues to
increase (2). This condition occurs more frequently
in developed countries, possibly due to increased
life expectancy, urbanization and changes in
lifestyle, but it has a greater impact on the population
of developing countries such as Mexico (3). In the
country, the situation of breast cancer is not
encouraging because it represents the leading
cause of death from neoplasms in Mexican women
(4).
The WHO states that early detection is a
fundamental strategy because through timely
diagnosis and appropriate treatment it is possible to
reduce the impact of the disease (3). For this reason,
preventive campaigns should focus on performing
mammograms or, in countries with lower per capita
income, on the use of self-examination as a
technique for detecting palpable lesions (3).
Currently, there is little investment in prevention
programs in developing countries and little response
from the population due to the lack of training in
health personnel and the low awareness of the
needs of this at-risk group (5).
One of the main issues in Mexico is the improvement
and expansion of screening aimed at promoting
early detection of breast cancer. In developed
countries, screening programs are applied and have
facilitated early detection and timely treatment of
breast cancer, giving patients a better quality of life.
These campaigns have proven to be highly
effective, which is why they have also begun to be
replicated in developing countries (6). Available data
suggest that only between 5 and 10% of cases in
Mexico are detected in the initial stages of the
disease (localized in the breast) compared to 50%
in the United States (7).
According to the Pan American Health Organization,
in 2012 breast cancer was the most common type of
cancer in Latin America. By 2030, the same
Organization estimates that the prevalence will
increase by 46%. In Mexico, breast cancer in
women over 20 years of age is the second cause of
death (8) and the first cause of cancer-related
mortality (9). Most cases are detected in advanced
stages, when the probability of 5-year survival with
treatment is less than 30%. Additionally, costs to
women, their families, and the health system are
higher, and treatments are more difficult, more
invasive, and less effective (8).
It is important to highlight the role of information and
recognize that citizens need to know the risks to
which they are exposed in order to act accordingly.
Researchers must address gaps in knowledge to
generate better practices in health promotion, as
well as develop better technologies, programs, in
order to establish better policies and clinical care (8).
Access to information about breast cancer,
accompanied by better medical care, could promote
greater survival, as happens in developed countries
(10).
Over a 10-year period and for every 1,000 women
undergoing mammographic screening, it is
observed that between 167 and 251 receive
abnormal results and are called for further testing, of
which approximately 56 to 64 undergo at least one
biopsy. Additionally, between 9 and 26 cases of
invasive cancer and three to six cases of ductal
carcinoma in situ (DCIS) are detected through
screening. Compared with women who refuse
screening, a reduction of 0.5 to 2 deaths from breast
cancer is observed during this period, depending on
the age of the women (11).
Recent increases in the use of mammography have
led to a decrease in breast cancer mortality.
Likewise, there is evidence that when patients are
informed about the diagnosis and the interventions
they will have, their feeling of control increases,
anxiety is reduced and their psychological
adjustment to the disease situation improves (12).
One research project assigned women to one of
three intervention groups: no educational materials
(usual care), standard materials, or adapted and
personalized materials. Those in the latter group
received materials based on their stage of adoption
for mammography. The primary outcome was
obtaining repeated mammograms, and women in
the group with tailored and personalized materials
were found to be more likely to obtain them
compared to those in the group without materials
(13).
This demonstrates the urgent need for health
education to promote early diagnosis of cancer and
timely treatment which the basis for improving the
quality of care for patients with breast cancer (10,
14). Furthermore, it contrasts with the findings of an
analysis of 58 pamphlets revealing that information
on mammography often focuses on incidence rather
than mortality, which is worrying given that
screening reduces mortality, but not incidence, and
can increase it by detecting harmless diseases (15).
A study of women in European and American
countries examined the understanding of the likely
benefits of mammography and found widespread
misconceptions. Most women believed that
screening prevents or reduces the risk of getting
breast cancer, or at least breast cancer mortality is
reduced by half. They also believed that 10 years of
regular screening will prevent 10 or more breast
cancer deaths per 1000 women (16). The greater
number of correct answers was positively
associated with a higher educational level and
negatively associated with having had a
mammogram in the last 2 years. The results suggest
that a high rate of women overestimate the benefits
that can be expected from mammographic
screening, raising questions about informed consent
procedures in breast cancer screening programs.
The main objective of Health Literacy is to enable
individuals to make informed and autonomous
decisions about their health. When facing health